Relationships between body mass index ( BMI ) , PAM50 , and recurrence-free and overall survival ( RFS and OS ) were evaluated using proportional hazards regression , adjusting for number of involved nodes , estrogen receptor ( ER ) status , tumor size , menopausal status , drug sequence , and dose density .